Novel form of s-omeprazole
AssigneeAstraZeneca AB
InventorsHanna Cotton, Anders Kronström, Anders Mattson, Eva Mõller
Life of this patent
Estimating the term…
Abstract
The present invention relates to a novel form of the (−)-enantiomer of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole, i.e. S-omeprazole. More specifically, it relates to a novel form of the magnesium salt of the S-enantiomer of omeprazole trihydrate. The present invention also relates to processes for preparing such a form of the magnesium salt of S-omeprazole and pharmaceutical compositions containing it. Furthermore, the present invention also relates to new intermediates used in the process.
Claims15
1-16. (canceled)
A method of treating Helicobacter infections comprising the administration of an effective amount of the magnesium salt of S-omeprazole trihydrate and an antibacterial compound to a patient in need thereof.
Dependencies are inferred from the claim text.